Early postoperative tumor progression predicts clinical outcome in glioblastoma—implication for clinical trials-Reference-Cited by-同舟云学术

Early postoperative tumor progression predicts clinical outcome in glioblastoma—implication for clinical trials

Published:2017-01-18 Issue:2 Volume:132 Page:249-254
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Merkel Andreas,Soeldner Dorothea,Wendl Christina,Urkan Dilek,Kuramatsu Joji B.,Seliger Corinna,Proescholdt Martin,Eyupoglu Ilker Y.,Hau Peter,Uhl Martin

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-016-2362-z.pdf

Reference16 articles.

1. Weller M, van den Bent M, Hopkins K et al (2014) EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. Lancet Oncol 15:e395–e403

2. Irwin C, Hunn M, Purdie G, Hamilton D (2007) Delay in radiotherapy shortens survival in patients with high grade glioma. J Neurooncol 85:339–343

3. Seidlitz A, Siepmann T, Lock S, Juratli T, Baumann M, Krause M (2015) Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme. Radiat Oncol 10:172

4. Loureiro LV, Victor Eda S, Callegaro-Filho D et al (2016) Minimizing the uncertainties regarding the effects of delaying radiotherapy for Glioblastoma: a systematic review and meta-analysis. Radiother Oncol 118:1–8

5. Han SJ, Rutledge WC, Molinaro AM et al (2015) The effect of timing of concurrent chemoradiation in patients with newly diagnosed glioblastoma. Neurosurgery 77:248–253

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 11C-methionine in the diagnostics and management of glioblastoma patients with rapid early progression: nonrandomized, open label, prospective clinical trial (GlioMET);BMC Cancer;2024-06-15

2. Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma;Clinical Cancer Research;2024-01-22

3. 11 C-methionine in the Diagnostics and Management of Glioblastoma Patients with Rapid Early Progression: Nonrandomized, Open Label, Prospective Clinical Trial (GlioMET);2024-01-03

4. Apparent Diffusion Coefficient Metrics to Differentiate between Treatment-Related Abnormalities and Tumor Progression in Post-Treatment Glioblastoma Patients: A Retrospective Study;Cancers;2023-10-14

5. Effects of Reoperation Timing on Survival among Recurrent Glioblastoma Patients: A Retrospective Multicentric Descriptive Study;Cancers;2023-04-28